2016-05-13T18:57:46-05:00 2015-06-30 346565596 ERNST & YOUNG US LLP 201 NORTH FRANKLIN STREET SUITE 2400 TAMPA FL 33602 990 2014-07-01 593238640 H LEE MOFFITT CANCER CENTER & RESEARCH INST LIFETIME CANCER SCREENING CTR INC HLEE 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 Yvette Tremonti EVP/CFO 8137457862 2016-05-13 1 MELANIE A MCPEAK P01346034 8132254800 2014 2016-08-17 19:52:53Z MOFFITT MEDICAL GROUP JOHNATHAN M LANCASTER 12902 MAGNOLIA DRIVE TAMPA FL 33612 75696341 0 X WWW.MOFFITT.ORG X 1994 FL TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBS. 14 11 538 29 0 0 246854 375772 71315631 75307613 0 0 0 12956 71562485 75696341 206087 205643 0 0 95546765 103733787 0 0 0 16272733 16837452 112025585 120776882 -40463100 -45080541 9281265 7180903 7365934 8000334 1915331 -819431 X TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCHINSTITUTE, INC (CANCER CENTER), H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL (HOSPITAL), AND H. LEE MOFFITT CANCER FOUNDATION BY EMPLOYING PHYSICIANS WHO STAFF THE HOSPITAL, BY MANAGING THEIR PRACTICE AND BY EMPLOYING THE CLINICAL SCIENTISTS WHO PROVIDE CLINICAL RESEARCH SERVICES. 0 0 111345131 205643 75307613 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. ("LCS") EMPLOYS THE PHYSICIANS (KNOWN AS THE MOFFITT MEDICAL GROUP) THAT STAFF THE HOSPITAL AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER HEALTH CARE SYSTEM. THE PROVISION OF PRACTICE MANAGEMENT SERVICES TO ITS EMPLOYED PHYSICIANS AND CLINICAL SCIENTISTS ENHANCES THE EFFICIENCY OF HEALTHCARE AND RESEARCH SERVICES PROVIDED BY THESE EMPLOYEES. THIS BENEFITS ALL ENTITIES IN THE CANCER CENTER HEALTH CARE SYSTEM AND PROMOTES AND SUPPORTS THE RESEARCH AND ACADEMIC MISSIONS OF THE CANCER CENTER HEALTH CARE SYSTEM. 111345131 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 14 0 1 538 1 0 0 0 0 0 0 0 0 0 0 X 14 11 1 0 1 0 1 1 1 1 0 0 0 1 1 1 1 1 1 0 0 0 X YVETTE M LYONS TREMONTI 8137457862 12902 MAGNOLIA DR TAMPA FL 33612 TIMOTHY J ADAMS DIRECTOR, CHAIR 1.00 1.00 X X 0 0 0 ALLAN MARTIN DIRECTOR, VICE CHAIR 1.00 0.00 X X 0 0 0 HONORABLE H LEE MOFFITT DIRECTOR, SECRETARY/TREASURER 1.00 4.00 X X 0 0 0 G DOUGLAS LETSON DIRECTOR,PRES 3/3/15,EVP-PIC 22.00 33.00 X X 0 773665 60961 JOEDRECKA BROWN SPEIGHTS MD DIRECTOR 1.00 0.00 X 0 0 0 FRANK CAPITANO DIRECTOR 1.00 0.00 X 0 0 0 HUGO FERNANDEZ MD DIRECTOR;SR MBR HEMONCMED 51.00 0.00 X 479133 0 61878 MICHAEL O'MALLEY DIRECTOR 1.00 0.00 X 0 0 0 ROBERT J PEREZ DIRECTOR 1.00 0.00 X 0 0 0 HONORABLE MARK A PIZZO DIRECTOR 1.00 1.00 X 0 0 0 JULIO M POW-SANG MD DIRECTOR, DEPT CHAIR UROLOGY 51.00 0.00 X 702503 0 69826 HONORABLE DONALD C SULLIVAN DIRECTOR 1.00 0.00 X 0 0 0 LORNA TAYLOR DIRECTOR 1.00 0.00 X 0 0 0 MARK WATSON DIRECTOR 1.00 0.00 X 0 0 0 JOHNATHAN M LANCASTER PRESIDENT TO 2/8/15 30.00 25.00 X 0 658937 71444 LOUIS D DE LA PARTE ASST SECRETARY 7.00 48.00 X 0 572125 77116 YVETTE M LYONS TREMONTI EVP-CFO & ASST TREASURER 7.00 48.00 X 0 586825 95657 WILLIAM FRANQUET VP REV CYCLE MGMT TO 11/10/14 20.00 35.00 X 0 213239 360 BRAULIO VICENTE JR VP PHYSICIAN GROUP OPERATIONS 20.00 35.00 X 0 425189 116696 JOANNA WEISS VP REV CYCLE MGMT 11/23/14 20.00 35.00 X 0 171780 32676 ROBERT A GATENBY DEPT CHAIR DIAGRADNON 55.00 0.00 X 650003 0 51359 DAVID N THRUSH DEPT CHAIR ANESTHESIOLOGY 55.00 0.00 X 641585 0 64609 CLAUDIA G BERMAN SR MBR DIAGRADNON 50.00 0.00 X 589091 0 39926 LARY ROBINSON SR MBR THORCARDIOLOGY 50.00 0.00 X 610862 0 30781 VERNON K SONDAK DEPT CHAIR GENSURGERY 55.00 0.00 X 658463 0 36427 DANIEL M SULLIVAN ACD CLINICAL SCIENCE 25.00 25.00 X 609922 0 62301 FOTIOS D VRIONIS SR MBR NEUROSURGERY 50.00 0.00 X 895232 0 44350 WILLIAM S DALTON FORMER PRES/CEO & CTR DIR 0.00 55.00 X 0 710012 82332 ALAN F LIST FORMER PRES & PIC 0.00 55.00 X 0 1236229 157192 JOHN A KOLOSKY FORMER EXEC VP COO 0.00 55.00 X 0 891899 214456 JANENE J CULUMBER FORMER SVP-CFO & ASST TREAS 0.00 0.00 X 0 452283 49237 DEAN R HEAD FORMER VP FACILITIES MGMT 0.00 0.00 X 0 167424 6774 MARK F HULSE FORMER VP & CIO 0.00 55.00 X 0 457538 64778 W J WILSON FORMER VP STRATEGIC COMM 0.00 55.00 X 0 325181 64150 DOMENICO COPPOLA FORMER SR MBR PATHANAT 50.00 0.00 X 372186 0 48164 MOKENGE MALAFA FORMER DEPT CHAIR GENSURG 55.00 0.00 X 587275 0 60381 RICHARD WILDER FORMER SR MBR RADONC 50.00 0.00 X 555504 0 41700 7351759 7642326 1705531 320 1 1 0 RANDY V HEYSEK MD PA PO BOX 90758 LAKELAND FL 33804 RADIATION ONCOLOGY SERVICES 245775 MEDICAL DOCTOR ASSOCIATES LLC PO BOX 277185 ATLANTA GA 30384 PROFESSIONAL MED SERVICES 141038 2 176088 1260 198424 375772 NET PROFESSIONAL FEES 900099 73180460 73180460 AFFILIATE SERVICES 900099 1186509 1186509 EHR MEDICARE INCENTIVE 900099 680541 680541 REIMBURSEMENTS 541900 188775 188775 QUALITY IMPROVEM PROG 900099 61338 61338 9990 9990 75307613 REFUND 900099 12956 12956 12956 75696341 75307613 0 12956 X 205643 205643 2770690 2743293 27397 1640270 1624051 16219 85958723 80829046 5129677 5127748 4903287 224461 4147667 3862542 285125 4088689 3777357 311332 236216 236216 49922 49922 1102797 487278 615519 394129 28072 366057 653118 51239 601879 1515804 1515804 737813 737813 319132 270601 48531 12540 12540 928344 2867 925477 1328747 1328747 ALLOC OF INTERCO EXP 0 4570741 -4570741 PURCHASED SERVICES 4390877 3703184 687693 BAD DEBT EXPENSE 2729646 2729646 PROFESSIONAL DEVELOP 1196220 1181779 14441 1242147 374505 867642 120776882 111345131 9431751 0 129800 9156455 6901089 11870 10500 63874 56769 10322 7105 102618 132409 9281265 7180903 7365934 8000334 7365934 8000334 X 1915331 -819431 1915331 -819431 9281265 7180903 X -45080541 42345779 X 0 1 X 1 0 X 1405329 1568535 763919 246854 375772 4360409 65621775 69671256 71154738 71315631 75307613 353071013 67027104 71239791 71918657 71562485 75683385 357431422 0 0 0 357431422 12956 12956 67027104 71239791 71918657 71562485 75696341 357444378 1.00000 1.00000 0.00000 X Schedule A, Part III, Line 12, Explanation of Other Income: REFUND - 2014 Amount: $ 12956. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 63874 56769 7105 7105 X Part X, Line 2: THE CANCER CENTER RECOGNIZES UNCERTAIN TAX POSITIONS WHEN IT IS MORE LIKELY THAN NOT (I.E., GREATER THAN 50% LIKELIHOOD OF RECEIVING BENEFIT) AND RECORDS THESE BENEFITS AT THE AMOUNT MOST LIKELY TO BE REALIZED ASSUMING A REVIEW BY TAX AUTHORITIES HAVING ALL RELEVANT INFORMATION AND APPLYING CURRENT CONVENTIONS. THE CANCER CENTER HAS NO SIGNIFICANT UNRECOGNIZED TAX BENEFITS AND DOES NOT BELIEVE THAT THERE WILL BE ANY MATERIAL CHANGES IN THE CANCER CENTER'S UNRECOGNIZED TAX POSITION OVER THE NEXT 12 MONTHS. 1 H LEE MOFFITT CC&RI INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 501(C)(3) 201643 INTERCOMPANY SUPPORT 1 0 Part I, Line 2: THE SCHEDULE I, PART II GRANT AMOUNTS REPRESENT INTERCOMPANY SUPPORT AND ARE ONLY MADE TO RELATED ORGANIZATIONS TO SUPPORT THEIR OPERATIONS. 1 1 0 0 0 1 1 0 0 G DOUGLAS LETSON DIRECTOR,PRES 3/3/15,EVP-PIC 0 525842 0 199113 0 48710 0 39909 0 26529 0 840103 0 0 HUGO FERNANDEZ MD DIRECTOR;SR MBR HEMONCMED 403442 0 70477 0 5214 0 38065 0 28560 0 545758 0 0 0 JULIO M POW-SANG MD DIRECTOR, DEPT CHAIR UROLOGY 588663 0 104073 0 9767 0 48579 0 26124 0 777206 0 0 0 JOHNATHAN M LANCASTER PRESIDENT TO 2/8/15 0 477983 0 177027 0 3927 0 56338 0 19815 0 735090 0 0 LOUIS D DE LA PARTE ASST SECRETARY 0 398178 0 149502 0 24445 0 56634 0 22593 0 651352 0 0 YVETTE M LYONS TREMONTI EVP-CFO & ASST TREASURER 0 413335 0 154970 0 18520 0 53864 0 43139 0 683828 0 0 WILLIAM FRANQUET VP REV CYCLE MGMT TO 11/10/14 0 180193 0 18271 0 14775 0 132 0 261 0 213632 0 0 BRAULIO VICENTE JR VP PHYSICIAN GROUP OPERATIONS 0 316739 0 90446 0 18004 0 89449 0 34206 0 548844 0 0 JOANNA WEISS VP REV CYCLE MGMT 11/23/14 0 143341 0 21771 0 6668 0 10321 0 23673 0 205774 0 0 ROBERT A GATENBY DEPT CHAIR DIAGRADNON 557819 0 84660 0 7524 0 37426 0 22139 0 709568 0 0 0 DAVID N THRUSH DEPT CHAIR ANESTHESIOLOGY 486398 0 149401 0 5786 0 52663 0 16643 0 710891 0 0 0 CLAUDIA G BERMAN SR MBR DIAGRADNON 458033 0 121611 0 9447 0 14541 0 26903 0 630535 0 0 0 LARY ROBINSON SR MBR THORCARDIOLOGY 520589 0 60157 0 30116 0 22920 0 9510 0 643292 0 0 0 VERNON K SONDAK DEPT CHAIR GENSURGERY 474011 0 166326 0 18126 0 22920 0 15002 0 696385 0 0 0 DANIEL M SULLIVAN ACD CLINICAL SCIENCE 422452 0 118664 0 68806 0 61853 0 6983 0 678758 0 0 0 FOTIOS D VRIONIS SR MBR NEUROSURGERY 757733 0 133061 0 4438 0 22920 0 22948 0 941100 0 0 0 WILLIAM S DALTON FORMER PRES/CEO & CTR DIR 0 643473 0 0 0 66539 0 65899 0 18346 0 794257 0 0 ALAN F LIST FORMER PRES & PIC 0 747090 0 371296 0 117843 0 100958 0 57732 0 1394919 0 0 JOHN A KOLOSKY FORMER EXEC VP COO 0 594853 0 220764 0 76282 0 192972 0 23367 0 1108238 0 0 JANENE J CULUMBER FORMER SVP-CFO & ASST TREAS 0 146187 0 0 0 306096 0 36222 0 17996 0 506501 0 0 DEAN R HEAD FORMER VP FACILITIES MGMT 0 55753 0 0 0 111671 0 4620 0 3168 0 175212 0 0 MARK F HULSE FORMER VP & CIO 0 329775 0 118016 0 9747 0 43099 0 22877 0 523514 0 0 W J WILSON FORMER VP STRATEGIC COMM 0 234276 0 80605 0 10300 0 50217 0 14954 0 390352 0 0 DOMENICO COPPOLA FORMER SR MBR PATHANAT 343134 0 19043 0 10009 0 24418 0 31117 0 427721 0 0 0 MOKENGE MALAFA FORMER DEPT CHAIR GENSURG 478632 0 101911 0 6732 0 37009 0 29361 0 653645 0 0 0 RICHARD WILDER FORMER SR MBR RADONC 467729 0 85652 0 2123 0 34075 0 14223 0 603802 0 0 0 Part I, Line 3 LCS RELIES ON H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, A RELATED ORGANIZATION WHICH USES AN INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEYS OR STUDIES, AN EXECUTIVE COMPENSATION COMMITTEE, AND THE APPROVAL BY THE BOARD OR THE EXECUTIVE COMPENSATION COMMITTEE OF THE BOARD, TO ESTABLISH THE PHYSICIAN IN CHIEF/PRESIDENT'S AND TOP MANAGEMENT OFFICIALS' COMPENSATION. Part I, Lines 4a-b THE FOLLOWING INDIVIDUALS RECEIVED SEVERANCE PAYMENTS INCLUDED IN COMPENSATION: JANENE J. CULUMBER, $226,950 DEAN HEAD, $ 83,432 THE FOLLOWING INDIVIDUALS PARTICIPATE IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AND AMOUNTS LISTED ARE INCLUDED IN THEIR TOTAL COMPENSATION LISTED IN SCH J, PART II, COLUMN B, RESPECTIVELY: ALAN F. LIST-$55,652 BRAULIO VICENTE-$9,073 JANENE J. CULUMBER-$22,882 LOUIS D. DE LA PARTE-$21,700 JOHN A. KOLOSKY-$47,819 G. DOUGLAS LETSON-$33,763 YVETTE M. LYONS TREMONTI-$16,365 W.J. WILSON-$0 WILLIAM S. DALTON-$0 DOMENICO COPPOLA-$0 ROBERTY A. GATENBY-$0 JULIO M. POW-SANG-$0 DANIEL M. SULLIVAN-$0 DAVID N. THRUSH-$0 RICHARD WILDER-$0 Part I, Line 6 IN GENERAL, INCENTIVE COMPENSATION IS BASED ON MOFFITT'S ACHIEVEMENT AGAINST SPECIFIC ORGANIZATIONAL GOALS RELATED TO NET OPERATING INCOME AND ON DIVISION OR INDIVIDUAL GOALS. NET OPERATING INCOME MUST MEET OR EXCEED A CERTAIN THRESHOLD IN ORDER TO TRIGGER A PAYOUT FOR THE ORGANIZATIONAL GOAL COMPONENTS. PATRICIA JUDSON SEE PART V 420770 SEE PART V 0 FORM 990, SCHEDULE L, PART IV INTERESTED PERSON: PATRICIA JUDSONRELATIONSHIP: FAMILY MEMBER OF JOHNATHAN LANCASTER, OFFICER TRANSACTION DESCRIPTION: COMPENSATION AS AN EMPLOYEE OF THE ORGANIZATION Form 990, Part VI, Section A, line 1 FAMILY MEMBER OF OFFICER, JOHNATHAN LANCASTER, WORKS FOR THE ORGANIZATION. Form 990, Part VI, Section A, line 2 THE FOLLOWING DIRECTORS AND OFFICERS, THAT JOINTLY SERVE ON H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. ("LCS") AND A FOR-PROFIT RELATED ENTITY, QUALIFY AS HAVING A BUSINESS RELATIONSHIP. LCS & MOFFITT TECHNOLOGIES CORPORATION: YVETTE LYONS TREMONTI, OFFICER LOUIS D. DE LA PARTE, OFFICER LCS & MOFFITT GENETICS CORPORATION: H. LEE MOFFITT, DIRECTOR YVETTE LYONS TREMONTI, OFFICER LOUIS D. DE LA PARTE, OFFICER Form 990, Part VI, Section A, line 4 CHANGES WERE MADE TO LCS'S SOLE MEMBER'S POWERS TO APPROVE OR DISAPPROVE IN EXCESS OF A STATED DOLLAR AMOUNT WHERE INDICATED IN THE ARTICLES AND BYLAWS. Form 990, Part VI, Section A, line 6 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. IS THE SOLE MEMBER OF LCS. Form 990, Part VI, Section A, line 7a AS THE SOLE MEMBER OF LCS, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. SHALL HAVE THE POWER TO APPROVE, DISAPPROVE OR REMOVE ANY MEMBER OF THE BOARD OF DIRECTORS OR OFFICER OF LIFETIME. Form 990, Part VI, Section A, line 7b H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (AS SOLE MEMBER) SHALL ALSO HAVE THE FOLLOWING POWERS: A. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE ARTICLES OF INCORPORATION OF THE CORPORATION; B. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE BYLAWS OF THE CORPORATION; C. APPROVE, DISAPPROVE OR RECOMMEND THE SELECTION OF A QUALIFIED AUDIT FIRM AND THE ANNUAL OPERATING AND CAPITAL BUDGETS OF THE CORPORATION; D. EITHER APPROVE OR DISAPPROVE THE TRANSFER, SALE, LEASE OR DISPOSITION OF ANY ASSET OF THE CORPORATION IN EXCESS OF TWO HUNDRED THOUSAND DOLLARS ($200,000.00); E. APPROVE OR DISAPPROVE THE CONFERRING OF ANY LIEN OR SECURITY INTEREST IN ASSETS OF THE CORPORATION IN EXCESS OF ONE MILLION DOLLARS ($1,000,000.00), WHETHER SAME SHALL BE IN CONNECTION WITH EITHER PUBLIC OR PRIVATE FINANCING, OR OTHERWISE; F. APPROVE OR DISAPPROVE ALL DONATIONS OR CHARITABLE CONTRIBUTIONS BY THE CORPORATION IN EXCESS OF TWENTY THOUSAND DOLLARS ($20,000.00) PER CONTRIBUTION OR ANNUAL CONTRIBUTION EXCEEDING FIFTY THOUSAND DOLLARS ($50,000.00) IN THE AGGREGATE; G. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION OF THE CORPORATION'S MISSION AND PHILOSOPHY STATEMENT; AND H. APPROVE OR DISAPPROVE CAPITAL EXPENDITURES BY THE CORPORATION IN EXCESS OF TWO HUNDRED THOUSAND DOLLARS ($200,000.00) PER EXPENDITURE OR FIVE HUNDRED FIFTY THOUSAND DOLLARS ($500,000.00) IN THE AGGREGATE ANNUALLY. Form 990, Part VI, Section A, line 8b LCS DOES NOT HAVE A COMMITTEE WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. Form 990, Part VI, Section B, line 11 LINE 11B, PRIOR TO PROVIDING FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, TO LCS BOARD OF DIRECTORS FOR REVIEW, THE CHIEF FINANCIAL OFFICER REVIEWS THE RETURN. SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED AND ANY NECESSARY CORRECTIONS ARE MADE. PRIOR TO ELECTRONICALLY FILING FORM 990, A COPY OF THE RETURN IS PROVIDED TO THE GOVERNING BODY, GIVING EACH BOARD MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. Form 990, Part VI, Section B, line 12c ON AN ANNUAL BASIS A PRESENTATION IS MADE TO LCS BOARD MEMBERS TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM ATTACHED TO THE POLICY. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTEREST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS/HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. Form 990, Part VI, Section B, line 15 LINE 15a & 15b, THE BOARD OF DIRECTORS OF H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. ("MOFFITT"), A RELATED ENTITY, HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE DIRECTORS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE PERFORMANCE AND COMPENSATION OF MOFFITT AND ITS SUBSIDIARIES' EXECUTIVES AND DISQUALIFIED PERSONS. THESE POSITIONS INCLUDE THE CEO, EXECUTIVE VICE PRESIDENTS, SENIOR VICE PRESIDENTS, VICE PRESIDENTS AND DEPARTMENT CHAIRPERSONS. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN AS NEEDED AND DOES AT ITS DISCRETION, ENGAGE OUTSIDE INDEPENDENT, OUTSIDE ADVISORS INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH EXECUTIVE, DISQUALIFIED PERSON AND INDIVIDUAL IN KEY POSITIONS. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED POSITION TO ITS APPROPRIATE MARKET EQUIVALENT. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE EXECUTIVE OR DISQUALIFIED PERSON CATEGORIES, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS ALONG WITH THE CONSULTANT'S COMPARABILITY DATA ARE PRESENTED TO THE JEC&BC FOR IT TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. EVERY THIRD YEAR THE INDEPENDENT CONSULTANT ANALYZES THE TOTAL EXECUTIVE COMPENSATION PROGRAM, USING THE SAME METHODOLOGY AS DESCRIBED ABOVE, THAT INCLUDEDS THE VALUE OF ALL BENEFITS AND PREREQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE EXECUTIVES AND DISQUALIFIED PERSONS. THE PURPOSE OF THE ANALYSIS IS TO PROVIDE AN OPINION ON THE REASONABLENESS OF EACH OF THE INDIVIDUAL COMPENSATION COMPONENTS AND THE AGGREGATE COMPENSATION TOTAL. THIS MORE COMPREHENSIVE ANALYSIS IS PROVIDED TO THE JEC&BC FOR THEIR USE IN THE ANNUAL REVIEW PROCESS. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED BACK TO THE FULL BOARD. Form 990, Part VI, Section C, line 19 LCS MAKES AVAILABLE TO THE PUBLIC THROUGH THIRD PARTY VENDORS' WEBSITES, ITS FORM 990 AND AUDITED FINANCIAL STATEMENTS. FORM 990 IS MADE AVAILABLE ON GUIDESTAR WHILE THE AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE ON DACBOND. ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND BYLAWS AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. Form 990, Part IX, Column (D): THERE ARE NO FUNDRAISING EXPENSES BECAUSE THE CONTRIBUTIONS ARE FROM RELATED ORGANIZATIONS AND OTHER GRANTS. H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. HANDLES ALL FUNDRAISING ACTIVITIES FOR H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBSIDIARIES. Form 990, Part XI, line 9: GRANT REFUNDS -23508. TRANSFER FROM TAX EXEMPT AFFILIATE 42369287. H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(c)(3) Line 3 H LEE MOFFITT CANCER CTR & RES INST INC 0 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 PARENT-RESEARCH FL 501(c)(3) Line 7 N/A 0 H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE FOUNDATION INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(c)(3) Line 7 H LEE MOFFITT CANCER CTR & RES INST INC 0 MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL N/A C 0 MOFFITT GENETICS CORPORATION 10902 N MCKINLEY DRIVE TAMPA FL 33612 208486180 DATABASE MANAGEMENT FL N/A C 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0